A high-throughput screening method for glycosaminoglycan backbone synthases
By constructing recombinant Bacillus subtilis BS168ASS and expressing the tuaD and glycosaminoglycan backbone synthase genes, the problem of high-throughput screening of glycosaminoglycan backbone synthases was solved by using luciferin click chemistry and fluorescence-activated cell sorting, thus achieving efficient screening and discovery of new enzymes.
Patent Information
- Application Number
- CN202210468072.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-04-29
- Publication Date
- 2026-07-24
- Estimated Expiration
- 2042-04-29
AI Technical Summary
Existing technologies lack high-throughput screening methods for glycosaminoglycan backbone synthases, making it difficult to effectively broaden the substrate range, change substrate specificity, and improve GTs activity. Furthermore, the lack of efficient methods for measuring fluorescence or absorbance changes makes the screening process difficult.
Recombinant Bacillus subtilis BS168ASS was constructed, expressing the uridine diphosphate-glucose-6-dehydrogenase gene tuaD and the glycosaminoglycan backbone synthase gene. The strain surface was made fluorescent by the Cyanine5 DBCO click chemical reaction, and high-throughput screening was achieved by combining fluorescence-activated cell sorting.
This method enables efficient and accurate screening of glycosaminoglycan backbone synthases, improving screening efficiency and providing a new starting point for the discovery of enzymes from novel sources. It is applicable to the discovery of novel glycosaminoglycan backbone synthases in metagenomic libraries.